CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,266 | -47.6% | 3,333 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $11,965 | +6.5% | 3,333 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,232 | +117.4% | 3,333 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $5,166 | +3.3% | 3,333 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $5,000 | -28.6% | 3,333 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $7,000 | -36.4% | 3,333 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $11,000 | -21.4% | 3,333 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $14,000 | -48.1% | 3,333 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $27,000 | +8.0% | 3,333 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $25,000 | -10.7% | 3,333 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $28,000 | +7.7% | 3,333 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $26,000 | 0.0% | 3,333 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $26,000 | – | 3,333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |